Low-dose of thalidomide in the treatment of refractory myeloma

Haematologica. 2000 Oct;85(10):1111-2.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial
  • Letter

MeSH terms

  • Aged
  • Angiogenesis Inhibitors / administration & dosage*
  • Angiogenesis Inhibitors / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Thalidomide / administration & dosage*
  • Thalidomide / therapeutic use
  • Treatment Outcome

Substances

  • Angiogenesis Inhibitors
  • Thalidomide